Skip to main content
Journal cover image

Economic end points in phase II trials.

Publication ,  Journal Article
Mark, DB; Simons, TA
Published in: Am Heart J
April 2000

Duke Scholars

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

April 2000

Volume

139

Issue

4

Start / End Page

S155 / S157

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Humans
  • Cost-Benefit Analysis
  • Clinical Trials, Phase II as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mark, D. B., & Simons, T. A. (2000). Economic end points in phase II trials. Am Heart J, 139(4), S155–S157. https://doi.org/10.1016/s0002-8703(00)90063-2
Mark, D. B., and T. A. Simons. “Economic end points in phase II trials.Am Heart J 139, no. 4 (April 2000): S155–57. https://doi.org/10.1016/s0002-8703(00)90063-2.
Mark DB, Simons TA. Economic end points in phase II trials. Am Heart J. 2000 Apr;139(4):S155–7.
Mark, D. B., and T. A. Simons. “Economic end points in phase II trials.Am Heart J, vol. 139, no. 4, Apr. 2000, pp. S155–57. Pubmed, doi:10.1016/s0002-8703(00)90063-2.
Mark DB, Simons TA. Economic end points in phase II trials. Am Heart J. 2000 Apr;139(4):S155–S157.
Journal cover image

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

April 2000

Volume

139

Issue

4

Start / End Page

S155 / S157

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Humans
  • Cost-Benefit Analysis
  • Clinical Trials, Phase II as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology